kabutan

Kringle Pharma,Inc., The Current Fiscal Year's Net Income to Widen

Wed Nov 13, 2024 3:40 pm JST Earnings

4884 Kringle Pharma,Inc. 【J-GAAP】

Earnings Report

Kringle Pharma,Inc. <4884> [TSE-G] announced its financial results after the market closed on November 13th (15:40). The net loss (non-consolidated) for the fiscal year ending September 2024 was loss of 756 million yen, a reduction in the deficit compared to loss of 756 million yen in the previous term. For the fiscal year ending September 2025, the loss is expected to be loss of 1.38 billion yen. This will mark the ninth consecutive term of losses.

In the most recent three-month period, from July to September (4Q), the net loss improved to a deficit of loss of 238 million yen (compared to a loss of 276 million yen in the same period last year). The operating profit/loss margin improved from -1488.9% in the same period last year to -1252.6%.

Kabutan News

Actual Results

Historical Performance
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Sep, 2022 391 -426 -330 -331 -68.3 0 Nov 14, 2022 J-GAAP
Sep, 2023 69 -888 -852 -854 -158.5 0 Nov 13, 2023 J-GAAP
Sep, 2024 80 -817 -754 -756 -118.2 0 Nov 13, 2024 J-GAAP
YoY +15.9% +8.0% +11.5% +11.5% +25.4%

Full Year Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Sep, 2024 Guidance 79 -1,003 -940 -942 -138.5 0 Aug 9, 2024 J-GAAP
Sep, 2024 Results 80 -817 -754 -756 -118.2 0 Nov 13, 2024 J-GAAP
Revision Rate +1.3% +18.5% +19.8% +19.7% +14.7%

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2023 43 -366 -365 -366 -60.2 0 May 13, 2024 J-GAAP
Oct - Mar, 2024 Guidance 0 Nov 13, 2024 J-GAAP
YoY

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Sep, 2023 69 -888 -852 -854 -158.5 0 Nov 13, 2023 J-GAAP
Sep, 2024 80 -817 -754 -756 -118.2 0 Nov 13, 2024 J-GAAP
Sep, 2025 Guidance 272 -1,379 -1,379 -1,380 -197.2 0 Nov 13, 2024 J-GAAP
YoY +240.0% -68.8% -82.9% -82.5% -66.8%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jul - Sep, 2023 18 -268 -275 -276 -51.2 -1,488.9 Nov 13, 2023 J-GAAP
Oct - Dec, 2023 18 -168 -169 -169 -29.5 -933.3 Feb 9, 2024 J-GAAP
Jan - Mar, 2024 25 -198 -196 -197 -32.4 -792.0 May 13, 2024 J-GAAP
Apr - Jun, 2024 18 -213 -152 -152 -24.3 -1,183.3 Aug 9, 2024 J-GAAP
Jul - Sep, 2024 19 -238 -237 -238 -37.2 -1,252.6 Nov 13, 2024 J-GAAP
YoY +5.6% +11.2% +13.8% +13.8% +27.3%

Related Articles